Back to News
Market Impact: 0.34

Rothschild Redburn downgrades Hermes stock rating on China concerns

Source: Investing.com

Analyst InsightsCompany FundamentalsConsumer Demand & RetailAnalyst Estimates
Rothschild Redburn downgrades Hermes stock rating on China concerns

Rothschild Redburn downgraded Hermès to Neutral from Buy and cut its price target to €1,410 from €1,835, citing difficult luxury-market conditions, particularly among its China-exposed core clientele. The firm reduced 2026-28 revenue forecasts by 2-6% and EPS estimates by 5-10%, now projecting 9% EPS CAGR for 2026-29. Hermès shares were down 39% year to date near a 52-week low, while RBC Capital separately downgraded the stock to Sector Perform and cut its target to €1,700 from €1,900.

Analysis

The relevant issue is not a near-term earnings miss but whether Hermès can preserve its scarcity premium as Chinese luxury demand becomes more selective. A 5-10% reduction in outer-year EPS assumptions can drive a disproportionately larger de-rating when the market is underwriting durable double-digit compounding; the shares may remain optically expensive even after a sharp decline if consensus growth continues to reset. This makes RMS more vulnerable than LVMH (MC.PA), whose earnings base has greater category and geographic diversification, while Kering (KER.PA) remains the higher-beta negative read-through due to its heavier fashion-turnaround execution risk.

The second-order effect is a shift in investor preference from brand quality to earnings visibility. Hermès' controlled distribution and pricing power protect gross margin, but they also limit the ability to offset weaker Chinese traffic through volume-led growth; incremental store investment and inventory commitments could therefore become a drag on operating leverage over the next 6-18 months. Richemont (CFR.SW) is a cleaner relative beneficiary if hard-luxury demand proves more resilient than leather goods, though its exposure to Chinese consumers prevents it from being a pure defensive trade.

Consensus may be too quick to extrapolate the China slowdown indefinitely: ultra-high-net-worth spending and constrained supply can stabilize faster than broader aspirational luxury demand. The actionable question is whether the next results show sequential improvement in Asia-Pacific ex-Japan sales and sustained pricing/mix without a deterioration in retail inventory or client acquisition. A positive revision to those indicators would challenge the de-rating thesis; absent that evidence, estimate risk likely persists through the next two reporting cycles.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately negative

Sentiment Score

-0.48

Ticker Sentiment

RMS-0.78

Key Decisions for Investors

  • Avoid initiating a directional RMS long solely on the decline; wait for the next earnings release to confirm stabilization in Asia-Pacific demand and management's ability to retain full-year margin guidance. The risk/reward is unfavorable while sell-side 2027-28 estimates are still being reset.
  • Express a 1-3 month relative-value view through long MC.PA / short RMS, sized beta-neutral. LVMH offers broader exposure to travel retail, beauty, spirits and US demand, whereas RMS remains more exposed to a multiple reset tied to a narrower leather-goods growth engine; cover if RMS reports clear sequential acceleration in Chinese demand.
  • For higher-risk luxury downside exposure, prefer short KER.PA over RMS on a basket basis, paired with long CFR.SW. Kering has both weak discretionary demand sensitivity and brand-execution risk, while Richemont provides relatively more exposure to resilient jewelry; reassess if Chinese luxury demand data inflects materially higher for two consecutive months.
  • Set an alert around the next RMS guidance update: any reaffirmation of medium-term growth alongside stable gross margin is not sufficient by itself—require evidence of improving regional sales trends. A renewed revenue or EBIT guidance cut would support maintaining the RMS underweight for 6-12 months.

More News

From AllMind Research

Browse all research